RainDance Technologies Appoints John A. Luckey VP of Product Development
News Oct 14, 2014
RainDance Technologies, Inc. has announced the appointment of John Luckey, Ph.D., as its new Vice President of Product Development.
Dr. Luckey brings more than 20 years of experience leading teams tasked with developing biotechnology systems and technology platforms. During his career, he has held senior product and platform development positions in companies including Roche NimbleGen, where he directed research and development activities for improving and expanding the company’s core DNA microarray synthesis technology and related instrumentation.
At Roche, he also liaised with 454 Life Sciences development teams and participated on the global team tasked with defining a strategy for applying NGS technology to high-value clinical diagnostics applications. Dr. Luckey also managed product development and engineering activities at MJ Research, contributing to the design and development of the Opticon product family and Opticon Monitor software.
In 1994, he founded GeneSys Technologies and brought to market the BaseStation DNA Fragment Analyzer, an ultrathin gel electrophoresis system that he had designed, developed and patented. Dr. Luckey holds a Ph.D. in Analytical Chemistry and an M.B.A. in Executive Management from the University of Wisconsin, Madison.
“RainDance has developed a unique and powerful core droplet technology that has the potential to transform the industry because of its unmatched ability to provide accurate, early detection and detailed quantitative analysis of rare genetic abnormalities from complex samples,” said Dr. Luckey. “I am honored to join a talented team dedicated to making a profound difference in the understanding of the genetic basis of disease states.”
“John’s appointment further demonstrates RainDance’s commitment to recruiting and building a team passionate about developing and commercializing a new generation of genomic technologies. We are focused every day on delivering the products our customers and partners need to succeed in disease research,” said Roopom Banerjee, President and CEO of RainDance Technologies.”
Complex Genetics Made Simple
RainDance Technologies offers an innovative product portfolio to research cell-free and cell-based biomarkers for hereditary risk predisposition, initial detection, pathology, and residual disease. The company’s products include:
• RainDrop® Digital PCR System: Ultra-sensitive digital PCR system for research of early detection and monitoring of biomarkers for cancers, viruses, pathogens, and immune disorders.
• ThunderBolts™ Cancer Panel: Next-Generation Sequencing (NGS) panel enabling highly sensitive, rapid, low input, and primary tumor profiling research in fresh biopsy, plasma and FFPE samples.
• ThunderStorm® NGS Content Enrichment System: High-throughput, fully automated NGS content enrichment solution enabling researchers to generate what we believe to be the best-in-class data on large-scale disease panels, while delivering affordable workflow for high-volume studies.
4000-Year Old DNA Helps Track the Spread of Rice Farming in AsiaNews
Rice farming spread far and wide in ancient Southeast Asia, but how it got there has been a mystery. Now, a study of 4000-year-old DNA—a rare find in this region—suggests it came with farmers migrating from China, where rice farming originated.
Underestimated Microscopic Problem For Coffee CropsNews
The plants which produce one of the most popular drinks in the world, coffee, are targeted by a microscopic worm, but scientists are fighting back. An underestimated problem in coffee farming, the parasite has been found in soil samples across the coffee growing world thanks to a new and quick detection method.
Island Life: Worm-eating Mice Hold Clues to EvolutionNews
How much space does a population need to branch out and form a new species? A small island in the Philippines, and four species of mice that live on it, have helped researchers work out the answer.READ MORE
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018